Revenue contracted 4.4% year-over-year in Q2 2026 despite a 31.1% sequential rebound, while gross margin surged to 33.9% from 14.8% a year earlier, indicating cost actions are driving profitability recovery.
Albemarle Corporation (ALB) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Sales/Revenue | 5.91B | 5.14B | 5.38B | 9.62B | 7.32B | 3.33B | 3.13B | 3.59B | 3.37B | 3.07B | 2.68B | 2.83B | 2.45B | 2.39B | 2.52B | 2.87B | 2.36B | 2.01B | 2.47B | 2.34B | 2.37B | 2.11B | 1.51B | 1.11B | 1.01B | 942.75M | 917.55M | 845.9M | 820.9M | 829.9M | 854.5M |
| Revenue Growth % | 18.32% | -4.37% | -44.08% | 31.38% | 119.96% | 6.36% | -12.83% | 6.35% | 9.86% | 14.75% | -5.28% | 15.57% | 2.14% | -4.96% | -12.19% | 21.43% | 17.82% | -18.71% | 5.6% | -1.36% | 12.38% | 39.22% | 36.34% | 10.15% | 6.91% | 2.75% | 8.47% | 3.05% | -1.08% | -2.88% | -31.32% |
| Cost of Goods Sold | 4.5B | 4.47B | 5.32B | 8.42B | 4.23B | 2.32B | 2.13B | 2.33B | 2.15B | 1.95B | 1.71B | 1.97B | 1.67B | 1.76B | 1.84B | 1.89B | 1.62B | 1.52B | 1.86B | 1.71B | 1.82B | 1.68B | 1.2B | 871.73M | 775.39M | 721.42M | 646.09M | 505.6M | 485M | 499.4M | 540.4M |
| COGS % of Revenue | - | 86.94% | 98.88% | 87.51% | 57.85% | 69.7% | 68.18% | 64.93% | 63.82% | 63.43% | 63.75% | 69.56% | 68.48% | 73.3% | 72.86% | 65.94% | 68.43% | 75.87% | 75.37% | 73.35% | 76.74% | 79.78% | 79.14% | 78.52% | 76.93% | 76.52% | 70.41% | 59.77% | 59.08% | 60.18% | 63.24% |
| Gross Profit | 1.41B | 671.62M | 60.24M | 1.2B | 3.09B | 1.01B | 995.55M | 1.26B | 1.22B | 1.12B | 970.58M | 860.23M | 770.85M | 861.4M | 910M | 977.06M | 745.92M | 483.86M | 607.67M | 622.49M | 550.81M | 426.15M | 315.75M | 238.51M | 232.53M | 221.34M | 271.46M | 340.3M | 335.9M | 330.5M | 314.1M |
| Gross Margin % | 23.89% | 13.06% | 1.12% | 12.49% | 42.15% | 30.3% | 31.82% | 35.07% | 36.18% | 36.57% | 36.25% | 30.44% | 31.52% | 35.98% | 36.12% | 34.06% | 31.57% | 24.13% | 24.63% | 26.65% | 23.26% | 20.22% | 20.86% | 21.48% | 23.07% | 23.48% | 29.59% | 40.23% | 40.92% | 39.82% | 36.76% |
| Gross Profit Growth % | - | 1014.92% | -94.98% | -61.08% | 205.97% | 1.3% | -20.91% | 3.09% | 8.69% | 15.75% | 12.83% | 11.6% | -10.51% | -5.34% | -6.86% | 30.99% | 54.16% | -20.37% | -2.38% | 13.01% | 29.25% | 34.97% | 32.38% | 2.57% | 5.06% | -18.47% | -20.23% | 1.31% | 1.63% | 5.22% | -15.36% |
| Operating Expenses | 707.37M | 577.83M | 696.25M | 959.89M | 584.13M | 475.81M | 469.84M | 573.46M | 496.74M | 500.92M | 460.94M | 389.63M | 443.44M | 245.13M | 400.25M | 389.22M | 324.12M | 273.55M | 322.42M | 307.66M | 284.15M | 261.4M | 189.01M | 145.69M | 129.71M | 122.89M | 121.3M | 215.5M | 210.1M | 209.7M | 220.7M |
| OpEx % of Revenue | - | 11.24% | 12.95% | 9.98% | 7.98% | 14.3% | 15.02% | 15.98% | 14.72% | 16.31% | 17.22% | 13.79% | 18.13% | 10.24% | 15.89% | 13.57% | 13.72% | 13.64% | 13.07% | 13.17% | 12% | 12.4% | 12.49% | 13.12% | 12.87% | 13.03% | 13.22% | 25.48% | 25.59% | 25.27% | 25.83% |
| Selling, General & Admin | 541.45M | 526.43M | 609.52M | 874.16M | 512.14M | 421.79M | 410.63M | 515.17M | 426.69M | 422.29M | 380.46M | 300.44M | 355.13M | 162.89M | 321.33M | 312.14M | 265.72M | 212.63M | 255.13M | 244.97M | 237.86M | 219.72M | 157.74M | 117.23M | 111.68M | 98.92M | 103.23M | 105.4M | 105.4M | 109.3M | 149.7M |
| SG&A % of Revenue | - | 10.24% | 11.33% | 9.09% | 7% | 12.67% | 13.12% | 14.35% | 12.64% | 13.75% | 14.21% | 10.63% | 14.52% | 6.8% | 12.76% | 10.88% | 11.25% | 10.6% | 10.34% | 10.49% | 10.04% | 10.43% | 10.42% | 10.56% | 11.08% | 10.49% | 11.25% | 12.46% | 12.84% | 13.17% | 17.52% |
| Research & Development | 37.69M | 51.4M | 86.72M | 85.72M | 71.98M | 54.03M | 59.21M | 58.29M | 70.05M | 84.33M | 80.47M | 89.19M | 88.31M | 82.25M | 78.92M | 77.08M | 58.39M | 60.92M | 67.29M | 62.69M | 46.3M | 41.67M | 31.27M | 18.41M | 16.48M | 21.92M | 26.2M | 34.3M | 29.7M | 31.4M | 30.44M |
| R&D % of Revenue | - | 1% | 1.61% | 0.89% | 0.98% | 1.62% | 1.89% | 1.62% | 2.08% | 2.75% | 3.01% | 3.16% | 3.61% | 3.44% | 3.13% | 2.69% | 2.47% | 3.04% | 2.73% | 2.68% | 1.95% | 1.98% | 2.07% | 1.66% | 1.64% | 2.33% | 2.86% | 4.05% | 3.62% | 3.78% | 3.56% |
| Other Operating Expenses | 2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.05M | 1.55M | 2.05M | -8.13M | 75.8M | 75M | 69M | 40.56M |
| Operating Income | 704.25M | 93.79M | -636.01M | 241.12M | 2.5B | 532.66M | 525.71M | 685.32M | 724.31M | 622.56M | 509.64M | 470.61M | 327.4M | 616.27M | 509.75M | 587.84M | 421.81M | 210.32M | 285.25M | 314.83M | 266.66M | 164.75M | 126.73M | 92.82M | 102.82M | 98.45M | 150.16M | 124.8M | 125.8M | 120.8M | 93.4M |
| Operating Margin % | 11.92% | 1.82% | -11.83% | 2.51% | 34.17% | 16.01% | 16.8% | 19.09% | 21.46% | 20.27% | 19.04% | 16.65% | 13.39% | 25.74% | 20.23% | 20.49% | 17.85% | 10.49% | 11.56% | 13.48% | 11.26% | 7.82% | 8.37% | 8.36% | 10.2% | 10.44% | 16.37% | 14.75% | 15.32% | 14.56% | 10.93% |
| Operating Income Growth % | - | 114.75% | -363.77% | -90.36% | 369.62% | 1.32% | -23.29% | -5.38% | 16.34% | 22.16% | 8.29% | 43.74% | -46.87% | 20.9% | -13.28% | 39.36% | 100.56% | -26.27% | -9.4% | 18.07% | 61.86% | 29.99% | 36.53% | -9.72% | 4.44% | -34.44% | 20.32% | -0.79% | 4.14% | 29.34% | -20.17% |
| EBITDA | 1.5B | 754.37M | -45.07M | 671.07M | 2.8B | 786.66M | 757.7M | 898.81M | 925.01M | 819.49M | 735.81M | 730.68M | 430.98M | 723.64M | 608.77M | 684.59M | 517.38M | 310.83M | 396.94M | 421.69M | 379.61M | 282.18M | 224M | 176.84M | 183.42M | 176.06M | 223.91M | 200.6M | 200.8M | 189.8M | 164.4M |
| EBITDA Margin % | 25.34% | 14.67% | -0.84% | 6.98% | 38.28% | 23.64% | 24.22% | 25.04% | 27.41% | 26.68% | 27.48% | 25.85% | 17.62% | 30.22% | 24.17% | 23.86% | 21.9% | 15.5% | 16.09% | 18.05% | 16.03% | 13.39% | 14.8% | 15.93% | 18.2% | 18.68% | 24.4% | 23.71% | 24.46% | 22.87% | 19.24% |
| EBITDA Growth % | 244.46% | 1773.84% | -106.72% | -76.05% | 256.23% | 3.82% | -15.7% | -2.83% | 12.88% | 11.37% | 0.7% | 69.54% | -40.44% | 18.87% | -11.08% | 32.32% | 66.45% | -21.69% | -5.87% | 11.08% | 34.53% | 25.97% | 26.67% | -3.59% | 4.18% | -21.37% | 11.62% | -0.1% | 5.8% | 15.45% | -22.12% |
| D&A (Non-Cash Add-back) | 792.86M | 660.58M | 590.94M | 429.94M | 300.84M | 254M | 231.98M | 213.48M | 200.7M | 196.93M | 226.17M | 260.08M | 103.57M | 107.37M | 99.02M | 96.75M | 95.58M | 100.51M | 111.69M | 106.86M | 112.95M | 117.44M | 97.27M | 84.01M | 80.6M | 77.61M | 73.75M | 75.8M | 75M | 69M | 71M |
| EBIT | 437.35M | -100.68M | -882.77M | 2.22B | 3.33B | 290.86M | 525.71M | 685.32M | 724.31M | 622.56M | 509.64M | 470.61M | 327.4M | 616.27M | 509.75M | 587.84M | 421.81M | 210.32M | 285.25M | 314.83M | 266.66M | 194.65M | 88.67M | 92.82M | 102.82M | 98.45M | 150.16M | 124.8M | 125.8M | 120.8M | 93.4M |
| Net Interest Income | -172.78M | -207.65M | -165.62M | -116.07M | -122.97M | -61.48M | -73.12M | -57.7M | -52.41M | -115.35M | -65.18M | -81.65M | -41.36M | -31.56M | -32.8M | -37.57M | -25.53M | -24.58M | -38.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 172.78M | 207.65M | 165.62M | 116.07M | 122.97M | 61.48M | 73.12M | 57.7M | 52.41M | 115.35M | 65.18M | 81.65M | 41.36M | 31.56M | 32.8M | 37.57M | 25.53M | 24.58M | 38.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -431.34M | -402.12M | -412.39M | 1.86B | 704.26M | -303.27M | -24.67M | 7.2M | 159.65M | -91.28M | 65.26M | -131.88M | -78.48M | -40.11M | -97.09M | 6.54M | 8.27M | -27.72M | -78.78M | -12.43M | -108.24M | -14.82M | -54.89M | -4.77M | -1.71M | -1.25M | -2.66M | 3.9M | -3M | 100K | 159.7M |
| Pretax Income | 272.91M | -308.33M | -1.05B | 2.1B | 3.21B | 229.39M | 501.04M | 692.52M | 883.97M | 531.28M | 574.9M | 338.72M | 248.92M | 576.16M | 412.66M | 594.38M | 430.08M | 182.59M | 206.47M | 302.4M | 158.42M | 149.93M | 71.84M | 88.06M | 101.11M | 97.2M | 147.5M | 128.7M | 122.8M | 120.9M | 253.1M |
| Pretax Margin % | 4.62% | -6% | -19.5% | 21.84% | 43.79% | 6.89% | 16.01% | 19.29% | 26.19% | 17.29% | 21.47% | 11.98% | 10.18% | 24.06% | 16.38% | 20.72% | 18.2% | 9.11% | 8.37% | 12.94% | 6.69% | 7.11% | 4.75% | 7.93% | 10.03% | 10.31% | 16.08% | 15.21% | 14.96% | 14.57% | 29.62% |
| Income Tax | 90.71M | 156.88M | 87.08M | 430.28M | 390.59M | 29.45M | 54.42M | 88.16M | 144.83M | 431.82M | 96.26M | 11.13M | 18.48M | 134.44M | 80.43M | 104.13M | 87.76M | -7.03M | -6.54M | 55.08M | 2.19M | 27.59M | 17M | 13.89M | 28.09M | 29.03M | 45.73M | 39.9M | 38.1M | 40.9M | 97M |
| Effective Tax Rate % | 33.24% | -50.88% | -8.31% | 20.48% | 12.18% | 12.84% | 10.86% | 12.73% | 16.38% | 81.28% | 16.74% | 3.29% | 7.43% | 23.33% | 19.49% | 17.52% | 20.4% | -3.85% | -3.17% | 18.21% | 1.38% | 18.4% | 23.67% | 15.77% | 27.78% | 29.87% | 31% | 31% | 31.03% | 33.83% | 38.32% |
| Net Income | 224.18M | -510.63M | -1.18B | 1.57B | 2.69B | 123.67M | 375.76M | 533.23M | 693.56M | 54.85M | 643.67M | 334.91M | 133.32M | 413.17M | 311.54M | 392.11M | 315.78M | 178.37M | 194.2M | 229.69M | 142.97M | 114.87M | 54.84M | 71.94M | 73.02M | 68.17M | 101.78M | 88.8M | 84.7M | 80M | 156.1M |
| Net Margin % | 3.79% | -9.93% | -21.93% | 16.36% | 36.75% | 3.72% | 12.01% | 14.86% | 20.55% | 1.79% | 24.04% | 11.85% | 5.45% | 17.26% | 12.37% | 13.67% | 13.36% | 8.89% | 7.87% | 9.83% | 6.04% | 5.45% | 3.62% | 6.48% | 7.24% | 7.23% | 11.09% | 10.5% | 10.32% | 9.64% | 18.27% |
| Net Income Growth % | 124.12% | 56.71% | -174.96% | -41.5% | 2074.96% | -67.09% | -29.53% | -23.12% | 1164.47% | -91.48% | 92.2% | 151.21% | -67.73% | 32.62% | -20.55% | 24.17% | 77.04% | -8.15% | -15.45% | 60.66% | 24.46% | 109.46% | -23.78% | -1.47% | 7.12% | -33.02% | 14.61% | 4.84% | 5.88% | -48.75% | 99.62% |
| Net Income (Continuing) | 182.19M | -465.21M | -1.14B | 1.67B | 2.82B | 199.94M | 446.62M | 604.36M | 739.14M | 99.47M | 478.64M | 327.59M | 230.44M | 435.73M | 325.85M | 420.2M | 329.42M | 189.62M | 213.01M | 229.69M | 142.97M | 114.87M | 54.84M | 74.17M | 73.02M | 68.17M | 101.78M | 88.8M | 84.7M | 80M | 156.1M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 202.13M | 32.48M | -69.53M | 4.11M | 4.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 258.69M | 248.1M | 238.17M | 252.92M | 208.22M | 180.34M | 200.37M | 161.33M | 173.79M | 143.15M | 147.54M | 146.92M | 129.17M | 115.42M | 98.41M | 87.55M | 59.67M | 47.62M | 0 | 54.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 1.65 | -5.75 | -11.20 | 13.36 | 22.84 | 1.06 | 3.52 | 5.02 | 6.34 | 0.49 | 5.68 | 3.00 | 1.69 | 4.90 | 3.47 | 4.77 | 3.51 | 1.94 | 2.10 | 2.36 | 1.47 | 1.20 | 0.65 | 0.86 | 0.85 | 0.74 | 1.09 | 0.94 | 0.82 | 0.72 | 1.33 |
| EPS Growth % | 99.68% | 48.66% | -183.83% | -41.51% | 2054.72% | -69.89% | -29.88% | -20.82% | 1193.88% | -91.37% | 89.33% | 77.51% | -65.51% | 41.21% | -27.25% | 35.9% | 80.93% | -7.62% | -11.02% | 60.54% | 22.5% | 84.62% | -24.42% | 1.18% | 14.86% | -32.11% | 15.96% | 14.63% | 13.89% | -45.86% | 125.42% |
| EPS (Basic) | - | -5.75 | -11.20 | 13.41 | 22.97 | 1.07 | 3.53 | 5.03 | 6.40 | 0.49 | 5.73 | 3.01 | 1.69 | 4.93 | 3.49 | 4.82 | 3.54 | 1.95 | 2.13 | 2.41 | 1.51 | 1.24 | 0.66 | 0.87 | 0.87 | 0.75 | 1.11 | 0.95 | 0.82 | 0.73 | 1.33 |
| Diluted Shares Outstanding | 136.21M | 117.7M | 117.52M | 117.77M | 117.79M | 116.54M | 106.81M | 106.32M | 109.46M | 112.38M | 113.24M | 111.56M | 79.1M | 84.32M | 89.88M | 91.52M | 92.18M | 92.05M | 92.53M | 97.22M | 97.14M | 95.5M | 85.05M | 84.29M | 86.27M | 93.05M | 93.21M | 95.03M | 104.27M | 111.11M | 117.81M |
| Basic Shares Outstanding | 117.96M | 117.7M | 117.52M | 117.32M | 117.12M | 115.84M | 106.4M | 105.95M | 108.43M | 110.91M | 112.38M | 111.18M | 78.7M | 83.84M | 89.19M | 90.52M | 91.39M | 91.51M | 91.34M | 95.25M | 94.62M | 92.7M | 83.13M | 82.51M | 84.21M | 91.53M | 91.76M | 93.78M | 103.12M | 110.34M | 117.81M |
| Dividend Payout Ratio | - | - | - | 11.9% | 6.86% | 143.81% | 43.06% | 28.54% | 20.85% | 256.26% | 21.03% | 35.62% | 63.08% | 18.9% | 22.18% | 14.73% | 15.72% | 31.47% | 28.8% | 17.43% | 22.09% | 23.02% | 46.09% | 36.46% | 31.47% | 34.98% | 19.41% | 21.17% | 22.79% | 20.75% | 9.1% |
Quick answers to the most common questions about buying ALB stock.
For fiscal year 2025, Albemarle Corporation (ALB) reported total revenue of $5.14B. This represents a 501.8% increase compared to $854.5M in 1996.
Albemarle Corporation (ALB) reported a net loss of $510.6M for the fiscal year ending 2025.
Albemarle Corporation (ALB) reported an operating income of $93.8M, resulting in an operating profit margin of 1.8%. This margin reflects the operational efficiency of the business before interest and taxes.
Albemarle Corporation (ALB) generated $671.6M in gross profit for the year, representing a gross profit margin of 13.1%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Lithium price volatility and margin recovery sustainability
Metrics are mathematically derived from official filings.
Revenue Contraction Persists Despite Quarterly Rebound
Revenue declined 4.4% year-over-year in Q2 2026, though sequential growth of 31.1% suggests a potential bottom. According to the latest quarterly data, the top line remains below prior-year levels.
The 31.1% sequential revenue increase in Q2 2026 is the strongest quarter-over-quarter growth in the dataset, but year-over-year revenue is still down 4.4%, indicating that the recovery is not yet broad-based. The negative growth rates in prior quarters (ranging from -3.5% to -47.7%) reflect the severe downturn in lithium prices, and the recent uptick may be driven by price stabilization rather than volume expansion. Investors should monitor whether this sequential momentum can translate into sustained year-over-year growth, as the current trajectory suggests a cyclical trough rather than a new uptrend.
Gross Margin Recovery Signals Cost Discipline
Gross margin rebounded to 33.9% in Q2 2026 from 14.8% a year earlier, according to reported figures, indicating improved pricing and lower inventory costs. This recovery appears driven by cost actions and price resets.
The gross margin expansion from 14.8% in Q2 2025 to 33.9% in Q2 2026 is dramatic and suggests that the company has successfully navigated the high-cost inventory overhang that plagued earlier periods. The negative gross margins in 2024 (as low as -7.7%) were likely due to lower-of-cost-or-market adjustments, and the current recovery implies that those charges have been absorbed. However, the sustainability of this margin level depends on lithium prices remaining stable, as the company's cost structure remains sensitive to feedstock costs and energy prices.
Operating Leverage Amplifies Earnings Swing
Operating income swung from a loss of $30.5 million in Q3 2025 to a profit of $452.9 million in Q2 2026, as per the income statement, demonstrating significant operating leverage. SG&A expenses remained relatively flat, enhancing the impact of revenue growth.
The operating margin of 26.0% in Q2 2026 is the highest in the dataset, and it reflects not only the gross margin recovery but also disciplined SG&A spending, which has remained in the $120-$160 million range despite revenue fluctuations. This indicates that the company's fixed cost base is well-controlled, allowing incremental revenue to flow through to operating income. However, the volatility in operating income (from -$280.1 million in Q3 2024 to $452.9 million in Q2 2026) underscores the cyclicality of the business, and investors should expect continued swings if lithium prices remain volatile.
Earnings Quality Clouded by One-Time Items
Net income of $480.0 million in Q2 2026 contrasts sharply with a net loss of $414.2 million in Q4 2025, per financial statements, suggesting possible one-time gains or tax benefits. Stock-based compensation remains modest at $6.8 million.
The net margin of 27.5% in Q2 2026 is far above the operating margin of 26.0%, implying that non-operating items, such as equity income from unconsolidated investments (e.g., Greenbushes) or tax benefits, contributed significantly to net income. The company's share of Greenbushes earnings can be substantial and may not be sustainable if lithium prices decline. Additionally, the negative EPS in prior quarters (e.g., -$9.45 in Q3 2024) indicates that the company has recognized large impairments or losses, which may not recur. Investors should adjust for these items to assess underlying earnings power.
COGS Volatility Drives Profitability
Cost of goods sold fell to $1.2 billion in Q2 2026 from $1.5 billion in Q3 2024, as reported, reflecting lower input costs and inventory adjustments. R&D and SG&A expenses have been trimmed, indicating cost discipline.
The sharp reduction in COGS relative to revenue is the primary driver of the margin recovery, and it appears to be a combination of lower spodumene prices and the absence of inventory write-downs. R&D spending has been cut from $23.5 million in Q1 2024 to $3.7 million in Q2 2026, which may raise concerns about long-term innovation, but it also reflects a focus on near-term profitability. SG&A has also been reduced, though less dramatically, suggesting that management is prioritizing cost control in a challenging price environment.
Q2 2026 Marks a Turning Point
Q2 2026 stands out as the inflection quarter, with EPS of $3.22 versus a loss of $3.87 in Q4 2025, according to the data, driven by a sharp margin recovery. This suggests the trough may be behind.
The transition from negative operating income in Q3 2025 to a record operating margin of 26.0% in Q2 2026 indicates a fundamental shift in the company's profitability trajectory. The improvement is likely due to a combination of higher lithium prices, cost reductions, and the clearing of high-cost inventory. However, the sustainability of this inflection is uncertain, as it hinges on lithium demand and pricing. The company's raised guidance for 2026, as noted in recent context, supports the view that management sees this as a durable improvement, but investors should monitor quarterly results to confirm.
Recovery May Be Priced In, Risks Remain
Despite the strong Q2 2026 beat, revenue growth remains negative at -4.4% year-over-year, and net margin for the trailing twelve months is still -9.9%, per the data. This suggests the earnings recovery may be concentrated in one quarter.
Short-sellers could argue that the Q2 2026 earnings beat is not indicative of a sustained recovery, as revenue is still declining and the TTM net margin remains deeply negative. The company's reliance on lithium prices, which are notoriously volatile, means that the current margin expansion could reverse quickly if prices fall. Additionally, the low debt/equity ratio of 0.34% may indicate that the company has been deleveraging, but it also raises questions about its ability to fund future growth. Investors should be cautious about extrapolating the Q2 2026 results, especially given the gap between quarterly and TTM profitability.